Applied Therapeutics Announces Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial, Company Plans to Meet with FDA Regarding Potential NDA Submission
NEW YORK - Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet... | April 25, 2023